NCT04283240View on ClinicalTrials.gov

Sildenafil in Acute Pulmonary Embolism

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 1, 2015

Primary Completion Date

September 10, 2017

Study Completion Date

September 10, 2018

Conditions
Pulmonary Embolism
Interventions
DRUG

Sildenafil

50 mg sildenafil, one dose

DRUG

Placebo

Placebo

Trial Locations (1)

8200

Aarhus University Hospital, Aarhus

All Listed Sponsors
lead

University of Aarhus

OTHER

NCT04283240 - Sildenafil in Acute Pulmonary Embolism | Biotech Hunter | Biotech Hunter